← Search & browse all drugs

fluorocarbon blood substitutes

B05AA03

Forms & Strengths

Colloidal solution for intravenous use
Typically 30-40% w/v fluorocarbon concentration

Adult Dosing

Typically 2-4 mL/kg body weight
Dosage may vary depending on intended use and patient condition
Not a substitute for whole blood or blood components

Pediatric Dosing

Safety and efficacy not well established in pediatric patients
Dosing should be individualized under close medical supervision

Indications

Perioperative blood volume expansion
Resuscitation in hypovolemic shock
Limited use in certain diagnostic procedures, such as retinal angiography

Mechanism of Action

Increases intravascular blood volume
Delivers oxygen to tissues due to high solubility of oxygen in fluorocarbons

Contraindications

Known allergy to fluorocarbons
Severe anemia or other conditions requiring whole blood or blood component transfusion
Cerebral edema or other conditions of increased intracranial pressure

Adverse Reactions

Allergic reactions, such as anaphylaxis or hives
Respiratory issues, including dyspnea and bronchospasm
Cardiovascular effects, such as hypotension and tachycardia

Drug Interactions

Potential interactions with high-density lipoprotein (HDL) and other lipid-based therapies
May affect laboratory tests measuring total cholesterol and other lipids
Avoid use with known hepatotoxic agents due to potential increased risk of liver injury

Curated Content: Needs Vetting Before Put to Clinical Use